Hubei Kelawei Biopharmaceutical Co., Ltd. announced that it will raise CNY 39,580,000 in an equity round of funding on December 10, 2021. The transaction includes participation from returning investor, Shaanxi Kanghui Pharmaceutical Co., Ltd. The investor will hold 40% stake in the company post closing of the transaction. Of the total capital increase, CNY 5,213,280.66 will go to registered capital and CNY 34,366,193.4 will go to the capital reserve of the company. The registered capital of the company will increase from CNY 27,716,186.26 to CNY 32,929,467 post closing of the transaction. The transaction has been approved at the 16th meeting of the fourth board of directors and the eleventh meeting of the fourth board of supervisors of the investor.